OMNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Outset Medical, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$3.80−0.14 (-3.55%)
Close on Oct 19, 2026
- Market cap
- $70.75K
- P/E (TTM)
- –
- Dividend yield
- –
Outset Medical statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Electromedical & Electrotherapeutic Apparatus companies for comparison
Valuation
| Measure | Outset Medical | Industry median |
|---|---|---|
| Market Cap | $71.43M | $230.55M |
| Enterprise Value | $21.88M | $202.97M |
| PS Ratio | 0.61 | 3.11 |
| PB Ratio | 0.74 | 3.14 |
| P/TBV Ratio | 0.74 | 4.57 |
Enterprise value
| Measure | Outset Medical | Industry median |
|---|---|---|
| EV / Sales | 0.19 | 2.92 |
Income (trailing twelve months)
| Measure | Outset Medical | Industry median |
|---|---|---|
| Revenue | $117.80M | $102.39M |
| Gross Profit | $49.20M | $60.36M |
| Operating Income | -$66.04M | -$4.31M |
| Pretax Income | -$73.36M | -$2.26M |
| Net Income | -$74.29M | -$6.57M |
| EBITDA | -$62.72M | -$1.98M |
Margins
| Measure | Outset Medical | Industry median |
|---|---|---|
| Gross Margin | 41.8% | 55.1% |
| Operating Margin | -56.1% | -6.04% |
| Pretax Margin | -62.3% | -4.11% |
| Profit Margin | -63.1% | -10.5% |
| EBITDA Margin | -53.2% | -2.67% |
| FCF Margin | -33.0% | -0.30% |
Returns
| Measure | Outset Medical | Industry median |
|---|---|---|
| Return on Equity (ROE) | -59.2% | -19.2% |
| Return on Assets (ROA) | -28.0% | -13.3% |
| Return on Invested Capital (ROIC) | -92.9% | -4.11% |
| Return on Capital Employed (ROCE) | -33.3% | -9.07% |
Growth
| Measure | Outset Medical | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -1.26% | 8.85% |
| Revenue Growth (3Y CAGR) | 1.17% | 7.08% |
| Revenue Growth (5Y CAGR) | 19.1% | 11.8% |
Balance sheet
| Measure | Outset Medical | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $147.19M | $37.33M |
| Total Debt | $97.65M | $72.66M |
| Net Cash (Debt) | $49.55M | $3.92M |
| Net Cash Per Share | $2.64 | $0.28 |
| Equity (Book Value) | $96.34M | $57.36M |
| Book Value Per Share | $5.13 | $2.81 |
| Tangible Book Value | $96.34M | $10.71M |
| Working Capital | $183.96M | $54.64M |
Financial position
| Measure | Outset Medical | Industry median |
|---|---|---|
| Current Ratio | 5.19 | 2.50 |
| Quick Ratio | 4.02 | 1.54 |
| Debt / Equity | 1.01 | 0.38 |
| Interest Coverage | -4.81 | -1.81 |
Cash flow (trailing twelve months)
| Measure | Outset Medical | Industry median |
|---|---|---|
| Operating Cash Flow | -$38.32M | -$653.46K |
| Capital Expenditures | -$559.00K | -$3.69M |
| Free Cash Flow | -$38.88M | -$835.02K |
| FCF Per Share | -$2.07 | -$0.02 |
Efficiency
| Measure | Outset Medical | Industry median |
|---|---|---|
| Asset Turnover | 0.44 | 0.59 |
| Inventory Turnover | 1.38 | 2.21 |
| Revenue Per Employee | $380.01K | $322.57K |
| Profits Per Employee | -$239.65K | -$51.88K |
| Employee Count | 310 | 185 |
Dividends and yields
| Measure | Outset Medical | Industry median |
|---|---|---|
| Earnings Yield | -104.0% | -6.91% |
| FCF Yield | -54.4% | -0.56% |
Shares
| Measure | Outset Medical | Industry median |
|---|---|---|
| Shares Outstanding | 18,797,200 | 44,856,700 |
| Shares Change (YoY) | 129.5% | 3.35% |
| Shares Change (QoQ) | 1.45% | 0.27% |
| Float | 12,444,100 | 37,097,900 |
| Shares Held by Insiders | 33.8% | 10.6% |
| Shares Held by Institutions | 75.5% | 63.5% |
Taxes
| Measure | Outset Medical | Industry median |
|---|---|---|
| Income Tax | $936.00K | $1.52M |
Scores
| Measure | Outset Medical | Industry median |
|---|---|---|
| Altman Z-Score | -6.19 | 1.95 |
| Piotroski F-Score | 6 | 5 |
| Beneish M-Score | -3.20 | -2.64 |
Calculated by StockData from Outset Medical's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.